Clinilabs Hepatitis B Profile blood test kit and vial

The Silent Infection: Why Early Detection of Hepatitis B Matters

In the realm of healthcare, the phrase “prevention is better than cure” is a guiding principle. However, when prevention is not possible, early detection becomes the next best defence. This is particularly true for hepatitis B, a viral infection of the liver that often operates under the radar. Because the liver is a highly resilient organ, it can sustain significant damage before showing any outward signs of distress. This makes early detection of hepatitis B not just beneficial, but potentially life-saving.

The insidious nature of hepatitis B lies in its ability to remain asymptomatic for years, or even decades. The UK Health Security Agency (UKHSA) notes that many individuals living with chronic hepatitis B are unaware of their infection [1]. During this silent phase, the virus can slowly cause inflammation and scarring (cirrhosis) of the liver. By the time symptoms such as jaundice, severe fatigue, or abdominal pain appear, the liver damage may already be advanced. Early detection interrupts this silent progression, allowing for timely medical intervention.

Identifying a hepatitis B infection early opens the door to effective management strategies. While there is currently no cure for chronic hepatitis B, there are highly effective antiviral medications available. As the National Institute for Health and Care Excellence (NICE) outlines, these treatments can suppress the virus, reduce liver inflammation, and significantly lower the risk of developing severe complications like cirrhosis and liver cancer [2]. Early diagnosis also allows healthcare professionals to monitor the liver’s health regularly, ensuring that any changes are addressed promptly.

Furthermore, early detection plays a crucial role in preventing the transmission of the virus to others. Hepatitis B is highly infectious and can be passed on through unprotected sex, sharing needles, or from mother to baby during childbirth. Knowing your status allows you to take necessary precautions to protect your loved ones and close contacts. It also enables pregnant women to receive appropriate care to prevent transmitting the virus to their newborn babies, a practice that is standard within NHS maternity care [3].

Taking control of your health means not waiting for symptoms to appear. The Hepatitis B Profile from Clinilabs is a valuable tool in this proactive approach. By testing for key markers, including the Hep B Surface Ag and Hep B Core Total, this profile can help provide insight into whether you have a current or past infection. This knowledge empowers you to seek appropriate medical advice and take charge of your liver health. Early detection is a powerful step towards a healthier, more secure future.

Explore this topic

Continue reading the related articles in this series:

Related test: Hepatitis B Profile at Clinilabs.

References

[1] UK Health Security Agency (UKHSA). (2023). Don’t forget to check for hep – testing and treatment for hepatitis. https://ukhsa.blog.gov.uk/2023/05/18/dont-forget-to-check-for-hep-testing-and-treatment-for-hepatitis/
[2] National Institute for Health and Care Excellence (NICE). (2024). Hepatitis B (chronic): diagnosis and management. https://www.nice.org.uk/guidance/ng50
[3] NHS. (2024). Screening for hepatitis B in pregnancy. https://www.nhs.uk/pregnancy/keeping-well/screening-for-hepatitis-b/

Related Posts